GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 194 filers reported holding GW PHARMACEUTICALS PLC in Q1 2018. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $29,000 | +81.2% | 135 | 0.0% | 0.02% | +66.7% |
Q4 2020 | $16,000 | +23.1% | 135 | 0.0% | 0.01% | +9.1% |
Q3 2020 | $13,000 | -23.5% | 135 | 0.0% | 0.01% | -21.4% |
Q2 2020 | $17,000 | +41.7% | 135 | 0.0% | 0.01% | +27.3% |
Q1 2020 | $12,000 | -14.3% | 135 | 0.0% | 0.01% | +10.0% |
Q4 2019 | $14,000 | -12.5% | 135 | 0.0% | 0.01% | -16.7% |
Q3 2019 | $16,000 | -30.4% | 135 | 0.0% | 0.01% | -36.8% |
Q2 2019 | $23,000 | 0.0% | 135 | 0.0% | 0.02% | +11.8% |
Q1 2019 | $23,000 | +76.9% | 135 | 0.0% | 0.02% | +70.0% |
Q4 2018 | $13,000 | -43.5% | 135 | 0.0% | 0.01% | -33.3% |
Q3 2018 | $23,000 | +21.1% | 135 | 0.0% | 0.02% | +15.4% |
Q2 2018 | $19,000 | +26.7% | 135 | 0.0% | 0.01% | +18.2% |
Q1 2018 | $15,000 | -16.7% | 135 | 0.0% | 0.01% | -8.3% |
Q4 2017 | $18,000 | +28.6% | 135 | 0.0% | 0.01% | +33.3% |
Q3 2017 | $14,000 | 0.0% | 135 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $14,000 | -12.5% | 135 | 0.0% | 0.01% | -10.0% |
Q1 2017 | $16,000 | +6.7% | 135 | 0.0% | 0.01% | +11.1% |
Q4 2016 | $15,000 | -16.7% | 135 | 0.0% | 0.01% | -18.2% |
Q3 2016 | $18,000 | +50.0% | 135 | 0.0% | 0.01% | +57.1% |
Q2 2016 | $12,000 | +20.0% | 135 | 0.0% | 0.01% | +40.0% |
Q1 2016 | $10,000 | +11.1% | 135 | 0.0% | 0.01% | 0.0% |
Q4 2015 | $9,000 | -25.0% | 135 | 0.0% | 0.01% | -28.6% |
Q3 2015 | $12,000 | -29.4% | 135 | 0.0% | 0.01% | -22.2% |
Q2 2015 | $17,000 | +41.7% | 135 | 0.0% | 0.01% | +50.0% |
Q1 2015 | $12,000 | +33.3% | 135 | 0.0% | 0.01% | +50.0% |
Q4 2014 | $9,000 | -18.2% | 135 | 0.0% | 0.00% | -20.0% |
Q3 2014 | $11,000 | -21.4% | 135 | 0.0% | 0.01% | -28.6% |
Q2 2014 | $14,000 | – | 135 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 602,047 | $61,102,000 | 6.76% |
FT Options LLC | 36,847 | $3,740,000 | 5.64% |
SCOPIA CAPITAL MANAGEMENT LP | 2,988,019 | $303,254,000 | 4.80% |
FT Options LLC | 71,000 | $1,320,000 | 1.99% |
Rock Springs Capital Management LP | 373,000 | $37,856,000 | 1.75% |
Redmile Group, LLC | 338,536 | $34,358,000 | 1.70% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 362,724 | $36,813,000 | 1.66% |
Ghost Tree Capital, LLC | 50,000 | $5,075,000 | 1.08% |
Atika Capital Management LLC | 32,500 | $3,298,000 | 0.95% |
Sivik Global Healthcare LLC | 25,000 | $2,537,000 | 0.86% |